Matteo Lambertini comments on the early and advanced breast cancer trials that caught his attention at the 2021 ASCO Annual Meeting, including the OlympiA, ECOG-ACRIN EA1131, GeparNUEVO, DAWNA-1, and sysucc-002 studies (7:06).
00:00 - Introduction
00:29 - Early breast cancer studies
04:59 - Metastatic breast cancer studies